Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

Presentation TCT 2024

TCT 814: Cost-Effectiveness of Supersaturated Oxygen Delivery for Infarct Size Reduction in Patients With Anterior STEMI

Presenter: Katherine Vilain

October 29, 2024

Presentation TCT 2024

TCT 575: Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI)

Presenter: Tayyab Shah

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

Presenter: Richard Powell

October 28, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study

Caitlin E. Cox

July 30, 2024

News Daily News

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Michael O'Riordan

July 23, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Yael L. Maxwell

March 18, 2024

Advertisement

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

TCT 814: Cost-Effectiveness of Supersaturated Oxygen Delivery for Infarct Size Reduction in Patients With Anterior STEMI

TCT 575: Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI)

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

One-Year Clinical Outcomes and Long-term Cost-Effectiveness Using Propensity-Score Matching of Pooled PROMISE Studies and the CLariTI Registry for No-Option CLTI Patients

Statins Are Cost-effective in the Elderly

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content